Combination Therapy Enhances Treatment Outcomes in Advanced Triple-Negative Breast Cancer
A groundbreaking study emerging from the Icahn School of Medicine at Mount Sinai illuminates a promising new avenue in the ...
A groundbreaking study emerging from the Icahn School of Medicine at Mount Sinai illuminates a promising new avenue in the ...
In a promising advancement for breast cancer therapeutics, researchers have uncovered a potent synergy between Tanshinone IIA, a bioactive compound ...
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative ...
In a groundbreaking study published recently in Nature Communications, researchers have unveiled a novel immunomodulatory strategy that promises to revolutionize ...
In the dynamic landscape of cancer research, the quest for innovative treatment avenues remains paramount, particularly in the context of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine